In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Opt-e-scrip Inc.

Latest From Opt-e-scrip Inc.

Start-Up Previews (4/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, The New Wave in Gastroenterology, features profiles of Algenix Inc., IntraPace Inc., MediGus Ltd. and Semorex Inc. Plus these Selected Start-Ups across Health Care: Isogenica Ltd., Opt-e-scrip Inc., Renovis Inc. and LLC.

Opt-e-scrip Inc.

Successful clinical trials are no guarantee that today's blockbusters will work in the general population. Opt-e-scrip Inc. has developed a method by which doctors can assess true drug response in their patients: statistically valid single-patient clinical trials designed to measure individual reactions to FDA-approved drugs.
BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Opt-e-scrip Inc.
  • Senior Management
  • Frederic J Huser, Chmn. & CEO
  • Contact Info
  • Opt-e-scrip Inc.
    Phone: (973) 699-3850
    25 Lindsley Dr.
    Ste. 203
    Morristown, NJ 07960